Mathematical model of heterogeneous cancer growth with an autocrine signalling pathway

Cell Proliferation - Tập 45 Số 5 - Trang 445-455 - 2012
G.‐M. Hu1, Chih-Yu Lee1, Yanhui CHEN2, Ning-Ning Pang1, Wen-Jer Tzeng3
1Physics Department, National Taiwan University, Taipei, Taiwan
2National Center for Theoretical Sciences Physics Department Institute of Astrophysics National Taiwan University Taipei Taiwan
3Physics Department Tamkang University New Taipei City Taiwan

Tóm tắt

AbstractObjectivesCancer is a complex biological occurrence which is difficult to describe clearly and explain its growth development. As such, novel concepts, such as of heterogeneity and signalling pathways, grow exponentially and many mathematical models accommodating the latest knowledge have been proposed. Here, we present a simple mathematical model that exhibits many characteristics of experimental data, using prostate carcinoma cell spheroids under treatment.Materials and methodsWe have modelled cancer as a two‐subpopulation system, with one subpopulation representing a cancer stem cell state, and the other a normal cancer cell state. As a first approximation, these follow a logistical growth model with self and competing capacities, but they can transform into each other by using an autocrine signalling pathway.Results and conclusionBy analysing regulation behaviour of each of the system parameters, we show that the model exhibits many characteristics of actual cancer growth curves. Features reproduced in this model include delayed phase of evolving cancer under 17AAG treatment, and bi‐stable behaviour under treatment by irradiation. In addition, our interpretation of the system parameters corresponds well with known facts involving 17AAG treatment. This model may thus provide insight into some of the mechanisms behind cancer.

Từ khóa


Tài liệu tham khảo

10.1038/35102167

10.1038/nm0909-1010

10.1016/j.ccr.2007.12.020

10.1158/0008-5472.CAN-09-2676

PiotrowskaMJ EnderlingH An der HeidenU MackeyMC(2008)Cancer and stem cells chapter 2 New York:Nova Science Publishers Inc.

10.1111/j.1365-2184.2006.00368.x

10.1111/j.1365-2184.2006.00369.x

10.1016/j.biosystems.2004.09.025

10.1111/j.1365-2184.2011.00739.x

10.1016/j.ejphar.2009.08.041

10.1098/rsta.2010.0221

10.1371/journal.pone.0014366

10.1111/j.1365-2184.2007.00434.x

Enmon R, 2003, Combination treatment with 17‐N‐allylamino‐17‐demethoxy geldanamycin and acute irradiation produces supra‐additive growth suppression in human prostate carcinoma spheroids, Cancer Res., 63, 8393

10.1038/nature06965

10.2174/156652409788488757